SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
March 20, 2025
 · 
5 min read
Press Releases
Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
March 13, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
March 6, 2025
 · 
6 min read
Press Releases
bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
February 25, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
January 22, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
January 13, 2025
 · 
5 min read
Press Releases
Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
December 17, 2024
 · 
4 min read
Press Releases
bioAffinity Technologies Set for Continued Expansion in 2025
December 12, 2024
 · 
5 min read
Press Releases
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
November 14, 2024
 · 
11 min read
Press Releases
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 4, 2024
 · 
5 min read
Load More
JOBS